EP4081664A4 - Optimisation du microbiome - Google Patents
Optimisation du microbiome Download PDFInfo
- Publication number
- EP4081664A4 EP4081664A4 EP20905639.9A EP20905639A EP4081664A4 EP 4081664 A4 EP4081664 A4 EP 4081664A4 EP 20905639 A EP20905639 A EP 20905639A EP 4081664 A4 EP4081664 A4 EP 4081664A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- microbiome
- optimization
- microbiome optimization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Databases & Information Systems (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Business, Economics & Management (AREA)
- Pathology (AREA)
- General Business, Economics & Management (AREA)
- Data Mining & Analysis (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Electroluminescent Light Sources (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962953068P | 2019-12-23 | 2019-12-23 | |
| US202063005243P | 2020-04-04 | 2020-04-04 | |
| US16/943,895 US12083304B2 (en) | 2019-12-23 | 2020-07-30 | Kits for topical, isotonic compositions |
| US202063075132P | 2020-09-05 | 2020-09-05 | |
| PCT/US2020/066269 WO2021133697A1 (fr) | 2019-12-23 | 2020-12-19 | Optimisation du microbiome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4081664A1 EP4081664A1 (fr) | 2022-11-02 |
| EP4081664A4 true EP4081664A4 (fr) | 2024-01-10 |
Family
ID=76574670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20905639.9A Pending EP4081664A4 (fr) | 2019-12-23 | 2020-12-19 | Optimisation du microbiome |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4081664A4 (fr) |
| AU (1) | AU2020415366A1 (fr) |
| WO (1) | WO2021133697A1 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018013583A2 (fr) * | 2016-07-11 | 2018-01-18 | The Brigham And Women's Hospital, Inc. | Cocktail de lactobacillus vaginal médicinal |
| WO2020123559A1 (fr) * | 2018-12-11 | 2020-06-18 | Glyciome, Llc | Compositions topiques, isotoniques destinées à être utilisées par voie génitale |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6537538B2 (en) * | 2000-12-18 | 2003-03-25 | Rush-Presbyterian-St. Luke's Medical Center | Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| CA2609754C (fr) * | 2005-04-27 | 2012-01-10 | Shenzhen Phlora Biotechnology Limited | Compositions d'acide benzoique et de saccharides pour reguler et maintenir la flore bacterienne et l'acidite du vagin |
| WO2018044967A1 (fr) * | 2016-08-31 | 2018-03-08 | Virginia Commonwealth University | Administration locale de médicaments hypocholestérolémiants pour le traitement et la prévention d'une vaginose bactérienne |
| SG11201903162VA (en) * | 2016-10-09 | 2019-05-30 | Shenzhen Eulikan Biotechnology Co Ltd | Uses of bacteriostatic agent formula in preparing composition for vaginal use and composition for vaginal use |
-
2020
- 2020-12-19 AU AU2020415366A patent/AU2020415366A1/en active Pending
- 2020-12-19 EP EP20905639.9A patent/EP4081664A4/fr active Pending
- 2020-12-19 WO PCT/US2020/066269 patent/WO2021133697A1/fr not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018013583A2 (fr) * | 2016-07-11 | 2018-01-18 | The Brigham And Women's Hospital, Inc. | Cocktail de lactobacillus vaginal médicinal |
| WO2020123559A1 (fr) * | 2018-12-11 | 2020-06-18 | Glyciome, Llc | Compositions topiques, isotoniques destinées à être utilisées par voie génitale |
Non-Patent Citations (4)
| Title |
|---|
| IMBERT MARL�NE ET AL: "On the Iron Requirement of Lactobacilli Grown in Chemically Defined Medium", CURRENT MICROBIOLOGY, vol. 37, no. 1, 1 July 1998 (1998-07-01), New York, pages 64 - 66, XP093106353, ISSN: 0343-8651, DOI: 10.1007/s002849900339 * |
| ROUSSEAU V ET AL: "Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms", ANAEROBE, ELSEVIER, AMSTERDAM, NL, vol. 11, no. 3, 1 June 2005 (2005-06-01), pages 145 - 153, XP004807462, ISSN: 1075-9964, DOI: 10.1016/J.ANAEROBE.2004.12.002 * |
| See also references of WO2021133697A1 * |
| YANG LIN ET AL: "Bornyl acetate suppresses ox-LDL-induced attachment of THP-1 monocytes to endothelial cells", BIOMEDICINE & PHARMACOTHERAPY, vol. 103, 1 July 2018 (2018-07-01), FR, pages 234 - 239, XP093106343, ISSN: 0753-3322, DOI: 10.1016/j.biopha.2018.03.152 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020415366A1 (en) | 2022-07-14 |
| EP4081664A1 (fr) | 2022-11-02 |
| WO2021133697A1 (fr) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3867745A4 (fr) | Hyperpiler | |
| EP3781482A4 (fr) | Nano-satellite | |
| EP3712112A4 (fr) | Zéolite de type gis | |
| EP3976107A4 (fr) | Sonosensibilisation | |
| EP4034119A4 (fr) | Nouvelles méthodes | |
| EP4069235A4 (fr) | Associations | |
| EP4073971A4 (fr) | Configuration de quasi-colocalisation | |
| EP4069234A4 (fr) | Associations | |
| EP4003420A4 (fr) | Anticorps spécifiques de l'il-38 | |
| EP3951394A4 (fr) | Immunochromatographie | |
| EP4081664A4 (fr) | Optimisation du microbiome | |
| HK40116757A (zh) | 固态形式 | |
| EP4072433A4 (fr) | Système de traversée septale | |
| HK40073800A (en) | Cryosphere | |
| HK40081726A (en) | Combinations | |
| HK40081727A (en) | Combinations | |
| HK40081725A (en) | Combinations | |
| HK40081724A (en) | Combinations | |
| HK40081723A (en) | Combinations | |
| HK40085727A (en) | Combinations | |
| HK40085728A (en) | Combinations | |
| EP4069236A4 (fr) | Associations | |
| EP4069224A4 (fr) | Associations | |
| HK40076608A (en) | Il-38-specific antiobodies | |
| HK40069480A (en) | Rhamnose-polysaccharides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220721 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: C12Q0001688300 Ipc: A61K0031045000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20231211 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: G16H 50/20 20180101ALI20231205BHEP Ipc: G16H 50/30 20180101ALI20231205BHEP Ipc: G16H 40/67 20180101ALI20231205BHEP Ipc: G16H 40/63 20180101ALI20231205BHEP Ipc: G16H 20/13 20180101ALI20231205BHEP Ipc: G16H 10/40 20180101ALI20231205BHEP Ipc: A61P 15/00 20060101ALI20231205BHEP Ipc: G16H 20/10 20180101ALI20231205BHEP Ipc: C12Q 1/689 20180101ALI20231205BHEP Ipc: C12Q 1/6883 20180101ALI20231205BHEP Ipc: A61K 47/14 20170101ALI20231205BHEP Ipc: A61K 33/32 20060101ALI20231205BHEP Ipc: A61K 31/7016 20060101ALI20231205BHEP Ipc: A61K 31/045 20060101AFI20231205BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |